For the year ending 2025-12-31, HCWB made $54,232 in revenue. -$22,298,702 in net income. Net profit margin of -41117.24%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 54,232 | 2,566,792 | ||
| Cost of revenues | 43,386 | 1,607,389 | ||
| Net revenues | 10,846 | 959,403 | ||
| Research and development | 5,442,884 | 6,388,994 | ||
| Legal expenses | - | 15,910,480 | ||
| General and administrative | 7,701,281 | 6,839,596 | ||
| Legal expenses (recoveries), net | -1,470,809 | - | ||
| Impairment of long-lived asset | 1,500,000 | - | ||
| Reserve for credit losses and other expenses | - | 1,300,000 | ||
| Nonoperating loss | 0 | - | ||
| Total operating expenses | 13,173,356 | 30,439,070 | ||
| Loss from operations | -13,162,510 | -29,479,667 | ||
| Interest expense | 845,051 | 631,137 | ||
| Change in fair value of investment | -273,422 | - | ||
| Change in fair value of contingent liability | -1,055,826 | - | ||
| Loss on sale of put shares | -263,974 | - | ||
| Gain on extinguishment of liability | 5,461,046 | - | ||
| Other income, net | 68,376 | 86,990 | ||
| Net loss | -7,959,709 | -30,023,814 | ||
| Equity dividend to investor | 14,338,993 | - | ||
| Net loss attributable to common stockholders | -22,298,702 | - | ||
| Basic EPS | -10.63 | -0.77 | ||
| Diluted EPS | -10.63 | -0.77 | ||
| Basic Average Shares | 2,097,701 | 38,793,018 | ||
| Diluted Average Shares | 2,097,701 | 38,793,018 | ||
HCW Biologics Inc. (HCWB)
HCW Biologics Inc. (HCWB)